Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $3.1 million.

  • Selectis Health's Shares Outstanding (Weighted Average) changed 0.0% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.1 million for FY2024, which is 40.83% up from last year.
  • Per Selectis Health's latest filing, its Shares Outstanding (Weighted Average) stood at $3.1 million for Q3 2025, which was down 0.0% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Shares Outstanding (Weighted Average) registered a high of $3.1 million during Q1 2024, and its lowest value of $2.7 million during Q1 2021.
  • Over the past 5 years, Selectis Health's median Shares Outstanding (Weighted Average) value was $3.1 million (recorded in 2022), while the average stood at $3.0 million.
  • In the last 5 years, Selectis Health's Shares Outstanding (Weighted Average) plummeted by 9020.94% in 2021 and then soared by 1362.79% in 2022.
  • Quarter analysis of 5 years shows Selectis Health's Shares Outstanding (Weighted Average) stood at $2.8 million in 2021, then grew by 10.33% to $3.1 million in 2022, then grew by 0.02% to $3.1 million in 2023, then increased by 0.41% to $3.1 million in 2024, then changed by 0.0% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $3.1 million for Q2 2025, and $3.1 million during Q1 2025.